Table 3

Assumptions about current length of stay and discharge rates after RDTC protocol and anticipated reduction in ward bed use after the introduction of an RDTC

ConditionCurrent median LOS (days)Estimated proportion discharged at end of protocolLength of draft protocol (h)Annual reduction in ward bed use
Values in bold are estimates, other values based on local data or research from elsewhere. LOS data are derived only from patients admitted (including A&E ward).
Chest pain, suspected myocardial infarction2.50.8 6 430
Deliberate self harm0 0.95 6 −20
Suspected pulmonary embolus2.50.75 6 121
Head injury00.9 8 −11
Pneumonia80.7 12 1560
Suspected appendicitis20.8 12 122
Suspected cholecystitis30.8 24 311
Social problems1 0.75 4 −123
Suspected deep venous thrombosis8.5 0.75 6 527
Headache40.85 16 347
Exacerbation of COPD7 0.75 18 607
Cellulitis2 0.5 24 208
Pyelonephritis10.95 18 87
Abscess1 0.9 6 84
Transient ischaemic attack7 0.9 24 421
Exacerbation of asthma20.8 6 55
Vertigo3 0.85 12 96
First fit 1 0.8 12 −18
Exacerbation of congestive cardiac failure250.55 24 834
Pneumothorax0 0.95 6 −21
Upper gastrointestinal bleed1 0.95 16 65
Blunt chest trauma20.85 12 77
Hypoglycaemia 1 0.95 4 −2
Renal colic 1 0.8 12 −9
Smoke inhalation 1 0.9 12 −5
Dehydration6 0.9 12 123
Allergy 1 0.95 8 −1
Annual total5844
Daily average16.0